Mitochondria-Targeted Peptides Dramatically Reduce Heart Attack Size in Rats

Mitochondria-targeted peptides (SS-31/Bendavia) reduced myocardial infarct size by up to 60% in rats when given before or during reperfusion — demonstrating potent cardioprotection through mitochondrial protection.

Cho, Janghyun et al.·Coronary artery disease·2007·Moderate EvidenceAnimal StudyAnimal Study
RPEP-01216Animal StudyModerate Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Mitochondria-targeted peptides (SS-31 and analogs) reduced myocardial infarct size by up to 60% in rat ischemia-reperfusion, with efficacy when given before ischemia or at reperfusion — demonstrating potent cardioprotection through preservation of mitochondrial function.

Key Numbers

How They Did This

animal-study study on opioid-peptides, cardiovascular.

Why This Research Matters

Relevant for opioid-peptides, cardiovascular, neuroprotection.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Mitochondria-targeted peptides (SS-31 and analogs) reduced myocardial infarct size by up to 60% in rat ischemia-reperfusion, with efficacy when given
Evidence Grade:
moderate evidence.
Study Age:
Published in 2007.
Original Title:
Potent mitochondria-targeted peptides reduce myocardial infarction in rats.
Published In:
Coronary artery disease, 18(3), 215-20 (2007)
Database ID:
RPEP-01216

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Mitochondria-Targeted Peptides Dramatically Reduce Heart Attack Size in Rats

What was found?

Mitochondria-targeted peptides (SS-31/Bendavia) reduced myocardial infarct size by up to 60% in rats when given before or during reperfusion — demonstrating potent cardioprotection through mitochondrial protection.

Read More on RethinkPeptides

Cite This Study

RPEP-01216·https://rethinkpeptides.com/research/RPEP-01216

APA

Cho, Janghyun; Won, Kyungheon; Wu, DunLi; Soong, Yi; Liu, Shaoyi; Szeto, Hazel H; Hong, Mun K. (2007). Potent mitochondria-targeted peptides reduce myocardial infarction in rats.. Coronary artery disease, 18(3), 215-20.

MLA

Cho, Janghyun, et al. "Potent mitochondria-targeted peptides reduce myocardial infarction in rats.." Coronary artery disease, 2007.

RethinkPeptides

RethinkPeptides Research Database. "Potent mitochondria-targeted peptides reduce myocardial infa..." RPEP-01216. Retrieved from https://rethinkpeptides.com/research/cho-2007-potent-mitochondriatargeted-peptides-reduce

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.